Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A09934 | 31554528 | Br J Nutr | Randomised trial of chronic supplementation with a nutraceutical mixture in subjects with non-alcoholic fatty liver disease. | 2020 | Details |
| A09950 | 31547124 | J Clin Med | Is There a Link between Basal Metabolic Rate, Spleen Volume and Hepatic Growth Factor Levels in Patients with Obesity-Related NAFLD? | 2019 | Details |
| A09958 | 31543468 | Ann Hepatol | Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis. | 2019 | Details |
| A09959 | 31543467 | Ann Hepatol | Obesity and liver cancer. | 2019 | Details |
| A09971 | 31540048 | Int J Environ Res Public Health | NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome. | 2019 | Details |
| A09976 | 31538528 | Future Med Chem | Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease. | 2019 | Details |
| A09980 | 31538216 | Herz | Cardiac abnormalities in patients with nonalcoholic fatty liver disease : Insights from auxiliary examinations. | 2019 | Details |
| A09982 | 31537030 | Semin Liver Dis | Peculiarities of Cirrhosis due to Nonalcoholic Steatohepatitis (NASH). | 2019 | Details |
| A10013 | 31524533 | Expert Opin Investig Drugs | Multi-drug approaches to NASH: what's in the development pipeline? | 2019 | Details |
| A10020 | 31522189 | Am J Case Rep | Sugar and the Mosaic of Autoimmunity. | 2019 | Details |
| A10031 | 31519114 | Expert Opin Investig Drugs | GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH). | 2019 | Details |
| A10042 | 31516267 | J Clin Exp Hepatol | Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How? | 2019 | Details |
| A10052 | 31512278 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study. | 2019 | Details |
| A10068 | 31503515 | Am J Physiol Endocrinol Metab | HDL flux is higher in patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A10095 | 31488310 | Rev Gastroenterol Mex (Engl Ed) | Extrahepatic complications of non-alcoholic fatty liver disease: Its impact beyond the liver. | 2019 | Details |
| A10108 | 31482382 | Endocrine | Association between nonalcoholic fatty liver disease and cardiac function and structure-a meta-analysis. | 2019 | Details |
| A10135 | 31472085 | Liver Int | Metabolic syndrome, but not non-alcoholic fatty liver disease, increases 10-year mortality: A prospective, community-cohort study. | 2019 | Details |
| A10139 | 31470786 | Curr Pharm Des | A Mitochondrial Approach to Cardiovascular Risk and Disease. | 2019 | Details |
| A10149 | 31469122 | Pol Arch Intern Med | Serum pentraxin 3 concentration in patients with type 2 diabetes and nonalcoholic fatty liver disease. | 2019 | Details |
| A10172 | 31455011 | Int J Environ Res Public Health | Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications. | 2019 | Details |
| A10179 | 31447675 | Front Pharmacol | NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment. | 2019 | Details |
| A10197 | 31438482 | Int J Environ Res Public Health | Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way. | 2019 | Details |
| A10208 | 31432447 | Hepatol Int | Association of epicardial adipose tissue with non-alcoholic fatty liver disease: a meta-analysis. | 2019 | Details |
| A10216 | 31428204 | Diabetol Metab Syndr | Incidence and risk factors for metabolic syndrome among urban, adult Sri Lankans: a prospective, 7-year community cohort, follow-up study. | 2019 | Details |
| A10217 | 31428049 | Front Endocrinol (Lausanne) | The Liver in Children With Metabolic Syndrome. | 2019 | Details |
| A10231 | 31419571 | Clin Gastroenterol Hepatol | Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10236 | 31419372 | Liver Int | Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosis. | 2019 | Details |
| A10238 | 31418344 | Curr Vasc Pharmacol | What Does the Future Hold for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis? | 2019 | Details |
| A10244 | 31413575 | Neuropsychiatr Dis Treat | Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review. | 2019 | Details |
| A10248 | 31412686 | Genes (Basel) | Transcriptomic Analysis of Porcine Granulosa Cells Overexpressing Retinol Binding Protein 4. | 2019 | Details |
| A10257 | 31408914 | Mol Nutr Food Res | In Utero One-Carbon Metabolism Interplay and Metabolic Syndrome in Cardiovascular Disease Risk Reduction. | 2019 | Details |
| A10271 | 31404666 | Clin Gastroenterol Hepatol | Increasing Liver Fat Is Associated With Incident Cardiovascular Risk Factors. | 2019 | Details |
| A10275 | 31402618 | Ann Clin Transl Neurol | Abnormal fatty acid metabolism is a core component of spinal muscular atrophy. | 2019 | Details |
| A10276 | 31402538 | Liver Int | CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients. | 2019 | Details |
| A10308 | 31391339 | JCI Insight | The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis. | 2019 | Details |
| A10319 | 31388626 | Hepatol Commun | Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10324 | 31387736 | Lancet Gastroenterol Hepatol | Management of metabolic syndrome and cardiovascular risk after liver transplantation. | 2019 | Details |
| A10326 | 31387260 | Antioxidants (Basel) | Inhibition of Heme Oxygenase Antioxidant Activity Exacerbates Hepatic Steatosis and Fibrosis In Vitro. | 2019 | Details |
| A10356 | 31377187 | Nutr Metab Cardiovasc Dis | PNPLA3 gene polymorphism in Brazilian patients with type 2 diabetes: A prognostic marker beyond liver disease? | 2019 | Details |
| A10362 | 31374827 | Medicines (Basel) | Perspectives on Interval Exercise Interventions for Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A10373 | 31367159 | World J Gastroenterol | Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis via gut microbiota. | 2019 | Details |
| A10374 | 31366982 | Sci Rep | Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis. | 2019 | Details |
| A10419 | 31343128 | Pediatr Endocrinol Diabetes Metab | Usefulness of the metabolic syndrome diagnosis in obese children in clinical practice. | 2019 | Details |
| A10431 | 31338545 | Diabetologia | A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial. | 2019 | Details |
| A10435 | 31336926 | Nutrients | The Potential Use of Metabolic Cofactors in Treatment of NAFLD. | 2019 | Details |
| A10441 | 31336392 | J Gastroenterol Hepatol | Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A10444 | 31334554 | J Nutr | A Mediterranean Diet Rich in Extra-Virgin Olive Oil Is Associated with a Reduced Prevalence of Nonalcoholic Fatty Liver Disease in Older Individuals at High Cardiovascular Risk. | 2019 | Details |
| A10451 | 31332389 | Nat Med | Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice. | 2019 | Details |
| A10453 | 31330977 | Antioxidants (Basel) | Nutritional Importance of Carotenoids and Their Effect on Liver Health: A Review. | 2019 | Details |
| A10459 | 31328066 | Cureus | A Retrospective Study to Examine the Correlation of Bioelectrical Impedance Analysis with Shear-wave Elastography in Indian Patients with Non-alcoholic Fatty Liver Disease and Diabetes on Background Sodium-glucose Cotransporter-2 Inhibitor Therapy. | 2019 | Details |
| A10478 | 31319896 | Clin Epigenetics | Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome. | 2019 | Details |
| A10486 | 31315613 | BMC Endocr Disord | The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes. | 2019 | Details |
| A10502 | 31309820 | Curr Vasc Pharmacol | Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review. | 2019 | Details |
| A10535 | 31298151 | Curr Pharm Des | Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus. | 2019 | Details |
| A10549 | 31293021 | Phytother Res | The effects of black seed supplementation on cardiovascular risk factors in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled clinical trial. | 2019 | Details |
| A10551 | 31292564 | Nat Rev Rheumatol | Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions. | 2019 | Details |
| A10562 | 31290703 | J Med Food | Lycopene and Tomato Sauce Improve Hepatic and Cardiac Cell Biomarkers in Rats. | 2019 | Details |
| A10615 | 31270645 | Mol Cell Biochem | Apelin promotes hepatic fibrosis through ERK signaling in LX-2 cells. | 2019 | Details |
| A10631 | 31262497 | Am J Cardiol | Nonalcoholic Fatty Liver Disease Is Associated With Arterial Distensibility and Carotid Intima-Media Thickness: (from the Multi-Ethnic Study of Atherosclerosis). | 2019 | Details |
| A10639 | 31258620 | Therap Adv Gastroenterol | The anti-inflammatory potential of diet and nonalcoholic fatty liver disease: the ATTICA study. | 2019 | Details |
| A10641 | 31258135 | Turk J Gastroenterol | Non-alcoholic fatty liver disease: A growing public health problem in Turkey. | 2019 | Details |
| A10656 | 31251928 | Gastroenterology | Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017. | 2019 | Details |
| A10662 | 31246368 | Aliment Pharmacol Ther | Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity. | 2019 | Details |
| A10663 | 31246081 | Eur J Paediatr Dent | The sweet danger of added sugars. | 2019 | Details |
| A10677 | 31240043 | Acad Forensic Pathol | Fatty Liver and the Forensic Pathologist. | 2018 | Details |
| A10684 | 31236937 | Australas J Dermatol | Nonalcoholic fatty liver disease puts patients with psoriasis at greater cardiovascular risk. | 2019 | Details |
| A10688 | 31235168 | Diabetes Metab Syndr | Efficacy of a non-invasive model in predicting the cardiovascular morbidity and histological severity in non-alcoholic fatty liver disease. | 2019 | Details |
| A10697 | 31233672 | Eur J Neurol | Favorable impact of non-alcoholic fatty liver disease on the cerebral white matter hyperintensity in a neurologically healthy population. | 2019 | Details |
| A10707 | 31227825 | Hum Mol Genet | Recent advances in novel therapies for lipid disorders. | 2019 | Details |
| A10734 | 31216433 | J Ethnopharmacol | Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice. | 2019 | Details |
| A10738 | 31215262 | Expert Rev Gastroenterol Hepatol | Olive oil antioxidants and non-alcoholic fatty liver disease. | 2019 | Details |
| A10751 | 31210034 | Diabetes Metab J | Understanding Bile Acid Signaling in Diabetes: From Pathophysiology to Therapeutic Targets. | 2019 | Details |
| A10761 | 31206703 | J Physiol | Anti-inflammatory effects of oestrogen mediate the sexual dimorphic response to lipid-induced insulin resistance. | 2019 | Details |
| A10765 | 31204306 | Obes Res Clin Pract | Neighbourhood socioeconomic circumstances, adiposity and cardiometabolic risk measures in children with severe obesity. | 2019 | Details |
| A10777 | 31197470 | Acta Diabetol | Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patients. | 2019 | Details |
| A10783 | 31195434 | Gut Liver | Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A10792 | 31191323 | Front Pharmacol | Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10798 | 31187710 | Curr Protein Pept Sci | System Bioinformatic Approach Through Molecular Docking, Network Pharmacology and Microarray Data Analysis to Determine the Molecular Mechanism Underlying the Effects of Rehmanniae Radix Praeparata on Cardiovascular Diseases. | 2019 | Details |
| A10809 | 31178295 | Med Clin (Barc) | Recommendations for the detection, diagnosis and follow-up of patients with non-alcoholic fatty liver disease in primary and hospital care. | 2019 | Details |
| A10814 | 31176631 | Dig Liver Dis | Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic review. | 2019 | Details |
| A10826 | 31171889 | World J Gastroenterol | Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats. | 2019 | Details |
| A10831 | 31168845 | J Cell Biochem | Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial. | 2019 | Details |
| A10847 | 31160124 | Trends Pharmacol Sci | Genetic Insights for Drug Development in NAFLD. | 2019 | Details |
| A10878 | 31144261 | Curr Obes Rep | Ethnic Disparities in Adiposity: Focus on Non-alcoholic Fatty Liver Disease, Visceral, and Generalized Obesity. | 2019 | Details |
| A10893 | 31136997 | Top Antivir Med | Fatty liver disease in persons with HIV infection. | 2019 | Details |
| A10907 | 31131153 | Am J Cardiovasc Dis | Ramipril significantly attenuates the development of non-alcoholic steatohepatitis in hyperlipidaemic rabbits. | 2019 | Details |
| A10913 | 31127561 | Methods Mol Biol | Application of Stable Isotope Labels for Metabolomics in Studies in Fatty Liver Disease. | 2019 | Details |
| A10914 | 31126802 | Hepatobiliary Pancreat Dis Int | miR-222 targets ACOX1, promotes triglyceride accumulation in hepatocytes. | 2019 | Details |
| A10940 | 31113580 | Ann Hepatol | miR-182-5p Attenuates High-Fat -Diet-Induced Nonalcoholic Steatohepatitis in Mice. | 2020 | Details |
| A10956 | 31104523 | Expert Rev Gastroenterol Hepatol | A critical appraisal of the use of ultrasound in hepatic steatosis. | 2019 | Details |
| A10960 | 31101783 | Georgian Med News | RESULTS OF CORRECTION OF THE HEPATIC STEATOSIS ON THE BACKGROUND OF HYPERTENSION AND OVERWEIGHT WITH HELP OF ESSENTIAL PHOSPHOLIPID COMPLEX. | 2019 | Details |
| A10964 | 31101130 | Lipids Health Dis | The effect of bergamot polyphenolic fraction on lipid transfer protein system and vascular oxidative stress in a rat model of hyperlipemia. | 2019 | Details |
| A10966 | 31100460 | Clin Gastroenterol Hepatol | Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 Diabetes. | 2019 | Details |
| A10986 | 31090267 | J Zhejiang Univ Sci B | Bile-ology: from bench to bedside. | 2019 | Details |
| A10992 | 31089384 | Iran J Pharm Res | Reduction of Some Atherogenic Indices in Patients with Non-Alcoholic Fatty Liver by Vitamin D and Calcium Co-Supplementation: A Double Blind Randomized Controlled Clinical Trial. | 2019 | Details |
| A11001 | 31085337 | Clin Gastroenterol Hepatol | Alcoholic and Nonalcoholic Fatty Liver Disease and Incident Hospitalization for Liver and Cardiovascular Diseases. | 2019 | Details |
| A11022 | 31079449 | J Med Chem | Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic Steatosis. | 2019 | Details |
| A11029 | 31077075 | J Nucl Cardiol | Non-alcoholic fatty liver disease with reduced myocardial FDG uptake is associated with coronary atherosclerosis. | 2019 | Details |
| A11034 | 31075323 | J Hepatol | The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content. | 2019 | Details |
| A11046 | 31070259 | Hepatology | Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta-Analysis. | 2019 | Details |